摘要
近期，美国食品药品管理局公布了扎那米韦的最新安全性信息。扎那米韦在美国用于治疗成年人和7岁以上儿童中由甲型和乙型流感病毒所致的单纯性急性疾病，在出现症状的2天内用药。扎那米韦用于预防流感适用于成年人和5岁以上儿童。
出处
《临床合理用药杂志》
2010年第4期54-54,共1页
Chinese Journal of Clinical Rational Drug Use
同被引文献40
-
1World health organization. State of the art of vaccine research and development [EB/OL]. (2005-01)[2012-02-17].http://www. who.int/vaecine_research/documents/Dip%20814.pdf.
-
2NAIR H, BROOKS WA, KATZ M, et ol. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis[J]. Lancet, 2011, 378(9807) : 1917-1930.
-
3SUGAYA N. Widespread use of neuraminidase inhibitors in Japan[J]. J Infect Chemother, 2011, 17(5): 595-601.
-
4HOIZER CT, von ITZSTEIN M, JIN B, et al. Inhibition of sialidases from viral, bacterial and mammalian sources by analogs of 2 - deoxy - 2,3 - didehydro - N - acetylneuraminie acid modified at the C-4 position[J]. Glycoconj J, 1993, 10(1): 40- 44.
-
5PEGG MS, yon ITZSTEIN M. Slow- binding inhibition of sialidase from influenza virus [J]. Biochem Mol Biol Int, 1994, 32(5): 851-858.
-
6von ITZSTEIN M, WU WY, KOK GB, et al. Rational design of potent sialidase- based inhibitors of influenza virus replication [J]. Nature, 1993, 363(6428) : 418-423.
-
7World health organization. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses [EB/OL].(2010-02)[2012-02-17]. http://www. who.int/csr/resources/publications/swineflu/hlnl use antivirals _20090820/en/.
-
8HAYDEN FG, OSTERHAUS AD, TREANOR JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections[J]. N Engl J Med, 1997, 337(13) : 874-880.
-
9PUZELLI S, FACCHINI M, di MARTINO A, et al. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic[J]. Antiviral Res, 2011, 90(3): 205-212.
-
10HUANG P, LIANG LJ, HOU NM, et al. Phylogenetic,molecular and drug- sensitivity analysis of HA and NA genes of human H3N2 influenza A viruses in Guangdong, China, 2007-2011[J]. Epidemiol Infect, 2013, 141(5): 1061-1069.
二级引证文献3
-
1董虹,张欢欢,黄晴,曹日昇,周雅,胡一桥.高效液相色谱法测定扎那米韦含量及有关物质[J].中国新药杂志,2018,27(1):31-37. 被引量：1
-
2白辰,刘铁钢,徐竞男,马雪颜,李卓,于河,谷晓红.基于网络药理学的银翘散合桑菊饮加减方、麻杏石甘汤加减方与抗病毒西药作用机制比较——以2018初冬流行性感冒轻症为例[J].中医杂志,2019,60(11):928-934. 被引量：32
-
3成人流行性感冒抗病毒治疗共识专家组,蒋荣猛,金荣华,张文宏,韩冰,王森.成人流行性感冒抗病毒治疗专家共识[J].中华传染病杂志,2022,40(11):641-655. 被引量：4
-
1安文献,张启才.雷米封中毒检验方法[J].刑事技术,1979,4(4):26-29.
-
2康民.救急!别忘心痛定[J].医药世界,2000(4):45-45.
-
3FDA批准Relenza用于预防甲、乙型流感[J].齐鲁药事,2006,25(6):379-379.
-
4卞家蓉,修清玉.神经氨酸酶抑制剂扎那米韦的药理作用与临床应用[J].中国新药与临床杂志,2013,32(8):614-618. 被引量：3
-
5抗流感新药帕拉米韦氯化钠注射液获批[J].内科,2013,8(2):223-223.
-
6医药[J].中国医院院长,2009(20):88-88.
-
7杨荣成.选用口服神经氨酸酶抑制剂oseltamivir以预防流感[J].中华医学信息导报,2000,15(3):21-21.
-
8李顺海,刁传新.过量口服消炎痛误诊为破伤风1例报告[J].中国实用医药,2007,2(4).
-
9抗流感新药帕拉米韦氯化钠注射液获批[J].中国药房,2013,24(18):1706-1706.
-
10广东研发甲流病毒诊断试剂填补国内空白[J].今日药学,2009,19(10):6-6.
